Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients
Clinical trial NCT02354313 · UNKNOWN
Trial details
- NCT number
- NCT02354313
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2017-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.